Vital KSK Holdings, Inc.

3151

JP3778280002

VITAL KSK HOLDINGS, INC. is a Japan-based holding company, principally engaged in the wholesale of drugs. The Pharmaceutical Wholesale segment is engaged in the wholesale of pharmaceuticals, diagnostics, medical equipment, materials to hospitals, medical practitioners, pharmacies and other medical institutions. The others business is engaged in dispensing pharmacy business, retail of pharmaceutical products, wholesale of agricultural chemicals and veterinary drugs, transportation business, nursing care business, consulting services for medical institutions, property insurance agency business, real estate brokerage business, as well as parking business.

Sector

Pharmaceuticals

Calendar

30/07/2024 - Q1 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
VITAL KSK HOLDINGS, INC.	+24.14%	41Cr
MCKESSON CORPORATION	+18.64%	7.29TCr
CARDINAL HEALTH, INC.	-6.00%	2.35TCr
SINOPHARM GROUP CO. LTD.	+2.93%	867.33Cr
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+9.32%	851.01Cr
HUADONG MEDICINE CO., LTD	-25.47%	771.4Cr
H. LUNDBECK A/S	+13.37%	520.69Cr
EBOS GROUP LIMITED	+1.58%	422.59Cr
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+5.71%	408.39Cr
GALENICA AG	+1.24%	398.64Cr

Pharmaceuticals Wholesale

Delayed Japan Exchange Other stock markets 08:00:00 29/05/2024 am IST			5-day change	1st Jan Change
1,296 ^JPY	+0.47%		+7.73%	+24.14%

15/05	Caution Ahead of US Inflation Data Leaves Japanese Shares Subdued	MT
15/05	Vital KSK to Dispose of Treasury Shares Worth 108 Million Yen as Restricted Stock Compensation	MT

Caution Ahead of US Inflation Data Leaves Japanese Shares Subdued	15/05	MT
Vital KSK to Dispose of Treasury Shares Worth 108 Million Yen as Restricted Stock Compensation	15/05	MT
Vital KSK Board OKs Up to 3 Billion Yen Share Buyback	15/05	MT
Vital KSK Holdings, Inc. Announces Dividend for the Fiscal Year Ended March 31, 2024, Payable on June 5, 2024; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2025	14/05	CI
Vital KSK Holdings, Inc. announces an Equity Buyback for 2,000,000 shares, representing 3.85% for ¥3,000 million.	13/05	CI
Vital KSK Holdings, Inc. authorizes a Buyback Plan.	13/05	CI
Vital KSK Holdings, Inc. Revises Consolidated Earnings Guidance for the Year Ended March 31, 2024	07/02	CI
Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on November 6, 2023.	08/11	CI
Vital KSK Holdings, Inc.'s Equity Buyback announced on November 6, 2023, has closed with 600,000 shares, representing 1.18% for ¥669.6 million.	08/11	CI
Vital KSK Holdings, Inc. Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on December 5, 2023	06/11	CI
Vital KSK Holdings, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	06/11	CI
Vital KSK Holdings, Inc. announces an Equity Buyback for 700,000 shares, representing 1.38% for ¥840 million.	06/11	CI
Vital KSK Holdings, Inc. authorizes a Buyback Plan.	06/11	CI
Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on May 12, 2023.	25/23/25	CI
Vital KSK Holdings, Inc.'s Equity Buyback announced on May 12, 2023, has closed with 1,000,000 shares, representing 1.94% for ¥956.92 million.	22/23/22	CI
VITAL KSK HOLDINGS, INC. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2024	04/23/04	CI
VITAL KSK HOLDINGS, INC. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending March 31, 2024	04/23/04	CI
VITAL KSK HOLDINGS, INC. Provides Year End Dividend Guidance for the Fiscal Year Ending March 31, 2024	04/23/04	CI
Vital KSK Holdings, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	02/23/02	CI
Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on May 12, 2023.	03/23/03	CI
Vital KSK Announces Voting Results	30/23/30	CI
Vital KSK Holdings, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	12/23/12	CI
Vital KSK Holdings, Inc. announces an Equity Buyback for 1,000,000 shares, for ¥1,200 million.	12/23/12	CI
Vital KSK Announces Notice Regarding Shareholder Proposal	12/23/12	CI
Vital KSK Holdings, Inc. authorizes a Buyback Plan.	12/23/12	CI

Vital KSK Holdings, Inc.

Equities

3151

JP3778280002

Pharmaceuticals

Latest news about Vital KSK Holdings, Inc.

Chart Vital KSK Holdings, Inc.

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Pharmaceuticals Wholesale